新生隐球菌的酚氧化酶及用于菌种鉴定的研究

采用4％玉米浸汁咖啡酸琼脂(CACA)培养基。观察了具不同生物学特性的新生隐球菌的酚氧化酶活性,并对临床常见的多种酵母和酵母样真菌作了该酶的检测。结果,受试的3个变种、5种血清型和尿素酶阴性新生隐球菌均呈明确的阳性反应;150株常见酵母和酵母样真菌中43株新生隐球菌全部呈酚氧化酶阳性。107株其它酵母和酵母样真菌全部阴性。具各种不同生物学特性的新生隐球菌均特异性地产生酚氧化酶,用检测该酶的方法作该菌鉴定的特异性和敏感性均为100％,且可于72小时内得到结果。此外,结合尿素酶试验可以准确的鉴定出尿素酶阴性的新生隐球菌。     

新生隐球菌的生态学,流行病学,分子生物学及临床研究

在我国，对新生隐球菌已进行了较系统的研究，生态学方面，由鸽粪分离的环境株具有表型的多态性，包括新生变种的Ａ、Ｄ血清型及尿素酶阴性株，而这些多态性菌株均已在临床发现。分子生物学方面，Ｇ＋Ｃｍｏｌ％和核型已被进行分析。由ＰＦＧＥ分析所得到的有意义的信息是两个变种和５种血清型新生隐球菌株具有明显不同的核型谱。临床方面，研制的一种新的可同时检测酚氧化酶和尿素酶的培养基可用于该菌的临床鉴定。使用一种高渗培养     

我国新生隐球菌临床株基因型分析

为了解中国大陆地区新生隐球菌临床株基因型分布情况, 我们对来自我国中东部地区的18个省、直辖市的120株血清A型和9株血清B型新生隐球菌临床株采用PCR指纹分析、IGS序列测定和MLST(Multilocus sequencing test)方法进行分析。结果显示血清A型菌株的M13指纹图谱中主要条带与VNI型标准株相同, 但次要条带与VNI现有各亚型均不相符, 我们将这种新VNI亚型命名为VNIc型, 但VNIc型并不只分布在中国大陆, MLST分析显示中国大陆地区的VNIc型菌株同来自美国、日本、马拉维和巴西的7株菌株亲缘关系高达75, 提示VNIc型可能是一种世界范围内分布的基因型; 对血清A型菌株采用(GACA)4和URA-5 RFLP指纹分析则呈现与VNI标准株完全一致的主次条带; 9株血清B型菌株基因型为VGI型。本研究初步揭示了我国大陆地区新生隐球菌临床株的基因型分布。     

新生隐球菌的生态学、流行病学、分子生物学及临床研究

在我国,对新生隐球菌(Cryptococcus neoformans)已进行了较系统的研究。生态学方面,,由鸽粪分离的环境株具有表型的多态性,包括新生变种的A、D血清型及尿素酶阴性株,而这些多态性菌株均已在临床发现。分子生物学方面,G+Cmol％和核型已被进行分析。,由PFGE分析所得到的有意义的信息是两个变种和5种血清型新生隐球菌株具有明显不同的核型谱。临床方面,研制的一种新的可同时检测酚氧化酶和尿素酶的培养基可用于该菌的临床鉴定。使用一种高渗培养基诱导出于该菌的L-型,提示在感染期间L-型的形成可能与该病的慢性过程与复发有关。已证实氟康唑对治疗新生隐球菌病有良好的效果。进一步应重视联合治疗的可能性,例如使用氟康唑加二性霉素B脂质体。总之在我国对新生隐球菌的系统性研究已经初步开始进行,许多有意义的结果已经得到并且将进一步得到。     

利用微卫星标记研究新生隐球菌分子流行病学

目的 研究国内隐球菌临床分离株的遗传多态性和分子流行病学.方法 选择与新生隐球菌遗传相关的9个微卫星标记,分析这9个位点从1993 ～2009年国内分离到的新生隐球菌临床株遗传背景、来源及变异程度.结果 116株被研究的隐球菌临床分离株,主要归属于3个微卫星复合物(MC2,MC3和MC12),其中大部分为MC2(103株).8株菌株属于目前为止未被国内外认识的新复合物(MC12).结论 利用微卫星DNA多态性研究新生隐球菌分子流行病学有较大的应用价值.     

隐球菌感染体外血脑屏障模型的构建与应用

目的构建体外血脑屏障模型,并检测隐球菌不同菌株穿越血脑屏障的能力。方法本研究应用商品化的小鼠脑微血管内皮细胞系b END.3构建体外血脑屏障模型,并验证该模型应用于隐球菌穿越血脑屏障机制研究的可行性。通过构建模型,以非致病性的酿酒酵母作为阴性对照,比较新生隐球菌不同血清型标准株及基因缺陷株穿越体外血脑屏障能力的差异。结果跨膜电阻值(TEER)检测提示体外血脑屏障模型构建成功。检测结果显示酿酒酵母作为阴性对照穿越血脑屏障效率最低,新生隐球菌血清A型标准株H99穿越细胞屏障效率最强,血清D型标准株JEC21穿越细胞屏障效率显著低于H99。较之H99,黑色素酶缺陷株lac1裣穿越体外血脑屏障模型的效率没有显著差异;尿素酶缺陷株ure1裣效率显著下降(P0.05),约为标准株H99通过率的59.9%;荚膜缺陷株cap59裣突破体外血脑屏障模型效率最低,约为标准株H99的18%(P0.001)。结论隐球菌中枢系统感染体外模型成功构建。新生隐球菌突破血脑屏障的能力与其血清型以及荚膜、尿素酶等毒力因子的表达密切相关。     

获得性免疫缺陷综合征患者的新生隐球菌基因多态性研究

本文旨在调查2003 年1 月― 2007 年12 月分离自上海地区获得性免疫缺陷综合征( AIDS) 患者的新生隐球菌临床株的配型及基因型分布特征, 为隐球菌病的诊疗提供科学依据。首先以M13 为单引物对模板DNA 进行聚合酶链反应( PCR) 扩增, 参照标准株指纹图将临床株鉴定至基因型; 同时对12 株来自AIDS 患者的新生隐球菌临床株的内转录间隔区( ITS) 基因进行PCR 扩增、序列分析, 以CLUSTAL W1. 83 软件多重比对分析ITS序列的差别,MEGA3. 1 软件处理数据, NJ 法绘制系统进化树, Bootstrapping 法对系统进化树结果进行统计学检验, 区分新生隐球菌格鲁比变种、新生变种及格特变种菌株; 最后选用特异性引物PCR 特异性扩增相关基因, 鉴定α和a 配型。结果显示, 分离自上海地区的12 株隐球菌临床株中, 9 株( 75% ) 为VNⅠ基因型/ α配型菌株,3 株( 25%) 为VNⅡ基因型/ α配型菌株, 且ITS基因序列分析可将各临床株鉴定至变种水平。本研究提示, 分离自上海地区AIDS患者的新生隐球菌临床株存在一定的遗传多态性, 以VNⅠ基因型/ α配型菌株为主, 有少量VNⅡ基因型/ α配型菌株。     

隐球菌感染体外血脑屏障模型的构建与应用CSCD

目的构建体外血脑屏障模型,并检测隐球菌不同菌株穿越血脑屏障的能力。方法本研究应用商品化的小鼠脑微血管内皮细胞系b END.3构建体外血脑屏障模型,并验证该模型应用于隐球菌穿越血脑屏障机制研究的可行性。通过构建模型,以非致病性的酿酒酵母作为阴性对照,比较新生隐球菌不同血清型标准株及基因缺陷株穿越体外血脑屏障能力的差异。结果跨膜电阻值(TEER)检测提示体外血脑屏障模型构建成功。检测结果显示酿酒酵母作为阴性对照穿越血脑屏障效率最低,新生隐球菌血清A型标准株H99穿越细胞屏障效率最强,血清D型标准株JEC21穿越细胞屏障效率显著低于H99。较之H99,黑色素酶缺陷株lac1裣穿越体外血脑屏障模型的效率没有显著差异;尿素酶缺陷株ure1裣效率显著下降(P<0.05),约为标准株H99通过率的59.9%;荚膜缺陷株cap59裣突破体外血脑屏障模型效率最低,约为标准株H99的18%(P<0.001)。结论隐球菌中枢系统感染体外模型成功构建。新生隐球菌突破血脑屏障的能力与其血清型以及荚膜、尿素酶等毒力因子的表达密切相关。     

新疆首次临床分离新生隐球菌菌株分子鉴定、基因分型及体外药物敏感性研究

目的对新疆首次临床分离的5株新生隐球菌进行分子鉴定、RAPD-PCR基因分型及体外药物敏感性研究。方法5株新生隐球菌分子鉴定采用核糖体DNA大亚基(LSU rDNA)D1/D2基因区域分子鉴定。分子分型采用引物SEQ-6结合RAPD-PCR法扩增5株新疆临床分离新生隐球菌菌株及5株由上海长征医院提供分离自上海新生隐球菌菌株,根据扩增产物带型进行基因型判定。采用临床实验室标准化协会(CLSI)的酵母微量液基稀释法(M27-A3)测定5株新疆临床分离新生隐球菌菌株对6种抗真菌药(伏立康唑、伊曲康唑、两性霉素B、特比萘芬、氟康唑、5-氟胞嘧啶)的体外敏感性。结果 5株新疆临床分离隐球菌菌株经过D1/D2区域序列分析在基因Bank中比对后鉴定为新生隐球菌。5株新疆临床分离新生隐球菌和5株上海新生隐球菌菌株经RAPD-PCR法扩增,带型显示分为A、B、C、D 4个基因型,其中新疆5株菌株A型1株、其余4株均为B型,上海菌株B型为1株,C型3株、D型1株,5株新疆临床分离新生隐球菌株对伏立康唑、伊曲康唑、两性霉素B、特比萘芬的MIC值(μg/mL)范围依次为:0.062 5~0.25、0.25~1、0.125~0.5、1~2,对氟康唑、5-氟胞嘧啶MIC值较高,MIC值范围依次为:4~16、8~32。结论新疆临床分离5株隐球菌株采用D1/D2基因序列鉴定为新生隐球菌。RAPD-PCR分型显示新疆临床分离5株新生隐球菌株以B型基因型为主。A型和B型对伏立康唑、两性霉素B敏感,对伊曲康唑、特比萘芬剂量依赖型敏感,对氟康唑、5-氟胞嘧啶耐药。     

对两种新生隐球菌选择性培养基的比较研究孙钒*

比较鸟籽琼脂 (GASA ,Guizotiaabyssinicaseedagar)和咖啡酸玉米琼脂 (CACA ,Caffeicacidcommealagar)对新生变种和格特变种的培养效果 ,再同时用两种培养基分离鸽粪和澳洲赤桉标本中的新生隐球菌。结果表明 ,CACA对新生隐球菌的培养和选择性分离效果与GASA相同 ,能够用于新生隐球菌的选择性分离。     

Restriction fragment polymorphism in mitochondrial DNA of Cryptococcus neoformans

The restriction patterns of mitochondrial DNA from 20 isolates of the two varieties of Cryptococcus neoformans were compared. The patterns exhibited extensive heterogeneity among the isolates regardless of their serotype or varietal status. Hybridizations with cloned fragments of the conserved cytochrome oxidase gene from Saccharomyces cerevisiae exhibited at least seven patterns among the 20 isolates. There were, however, similarities in the restriction patterns among isolates within the same serotype that were not shared by isolates of other serotypes. Intra-varietal similarities were observed in the restriction patterns among the isolates of C. neoformans var. neoformans which were not present in the restriction patterns among the isolates of C. neoformans var. gattii. Hybridization of some cloned mitochondrial DNA fragments to total DNA digests of various isolates revealed polymorphic as well as variety-specific patterns of homology. These findings agree with the antigenic heterogeneity among the isolates and support the current taxonomic classification of C. neoformans into two varieties.     

Genomic typing of Escherichia coli O157:H7 by semi-automated fluorescent AFLP analysis

Escherichia coli serotype O157:H7 isolates were analyzed using a relatively new DNA fingerprinting method, amplified fragment length polymorphism (AFLP). Total genomic DNA was digested with two restriction endonucleases (EcoRI and MseI), and compatible oligonucleotide adapters were ligated to the ends of the resulting DNA fragments. Subsets of fragments from the total pool of cleaved DNA were then amplified by the polymerase chain reaction (PCR) using selective primers that extended beyond the adapter and restriction site sequences. One of the primers from each set was labeled with a fluorescent dye, which enabled amplified fragments to be detected and sized automatically on an automated DNA sequencer. Three AFLP primer sets generated a total of thirty-seven unique genotypes among the 48 E. coli O157:H7 isolates tested. Prior fingerprinting analysis of large restriction fragments from these same isolates by pulsed-field gel electrophoresis (PFGE) resulted in only 21 unique DNA profiles. Also, AFLP fingerprinting was successful for one DNA sample that was not typable by PFGE, presumably because of template degradation. AFLP analysis, therefore, provided greater genetic resolution and was less sensitive to DNA quality than PFGE. Consequently, this DNA typing technology should be very useful for genetic subtyping of bacterial pathogens in epidemiologic studies.     

A PCR-based DNA fingerprinting technique: AFLP for molecular typing of bacteria.

Amplified restriction fragment polymorphism (AFLP) is a PCR-based DNA fingerprinting technique. In AFLP analysis, bacterial genomic DNA is digested with restriction enzymes, ligated to adapters, and a subset of DNA fragments are amplified using primers containing 16 adapter defined sequences with one additional arbitrary nucleotide. Polymorphisms of different Escherichia coli strains or Agrobacterium tumefaciens strains were demonstrated as distinct, unique bands in a denaturing sequencing gel using AFLP. The polymorphisms detected between BL21 and BL21F'IQ and between DH5 alpha and DH5 alpha F'IQ strains indicated that AFLP is able to resolve differences in F' episomal DNA (approximately 100 kb).     

DNA fingerprinting of Cryptosporidium parvum isolates using amplified fragment length polymorphism (AFLP)

The genetic variability of 10 Cryptosporidium parvum isolates of human and animal origin was investigated using amplified fragment length polymorphism (AFLP). Analysis of fluorescent dye-labeled amplified products was carried out using an ABI PRISMS 377 DNA sequencer and ABI PRISMS GeneScan software. One-hundred and twelve primer combinations were evaluated using a single C. parvum isolate. The patterns generated were highly reproducible. For subsequent study, a subset of 9 primer pairs that yielded 30-90 DNA fragments after the polymerase chain reaction, within the size range of 50-500 bp, was used to screen the 10 C. parvum isolates, including 7 bovine, 1 equine, and 2 of human origin. The animal isolates produced identical fingerprint patterns with every primer combination tested. Of the 2 human isolates tested, 1 of the isolates, passaged in calves, generated the same AFLP DNA banding patterns as the animal isolates, whereas the other isolate, obtained directly from human feces, produced unique patterns. Polymorphism, detected by comparison of the fingerprint patterns of the latter human isolate with the common pattern shared by all other isolates, ranged from 17 to 35% for the 9 primer pairs. The results show that AFLP is a useful method for differentiating C. parvum isolates into 2 distinct genotypes.     

AFLP™ markers for DNA fingerprinting in cattle

This work reports on use of the recently described amplified fragment length polymorphism (AFLP) technology for DNA fingerprinting in cattle. The AFLP technology produces molecular markers through the high-stringency polymerase chain reaction (PCR)-amplification of restriction fragments that are ligated to synthetic adapters and amplified using primers, complementary to the adapters, which carry selective nucleotides at their 3' ends. While, for plants, the double digestion of genomic DNA with Eco RI and Mse I is suggested, in mammals the enzyme combination Eco RI/ Taq I produces clearer and more polymorphic AFLP patterns. In a sample of 47 Italian Holstein genotypes, 16 Eco RI/ Taq I primer combinations identified 248 polymorphic bands in a species known for its low level of restriction polymorphism. In spite of the low information content carried by each AFLP polymorphism (average polymorphism information content = 0·31), the number of fragments revealed by each primer combination increased significantly the level of genetic information gained in each experiment. AFLP patterns are reproducible in independent experiments and polymorphic fragments segregate in cattle families according to Mendelian rules.     

AFLP: a new technique for DNA fingerprinting.

A novel DNA fingerprinting technique called AFLP is described. The AFLP technique is based on the selective PCR amplification of restriction fragments from a total digest of genomic DNA. The technique involves three steps: (i) restriction of the DNA and ligation of oligonucleotide adapters, (ii) selective amplification of sets of restriction fragments, and (iii) gel analysis of the amplified fragments. PCR amplification of restriction fragments is achieved by using the adapter and restriction site sequence as target sites for primer annealing. The selective amplification is achieved by the use of primers that extend into the restriction fragments, amplifying only those fragments in which the primer extensions match the nucleotides flanking the restriction sites. Using this method, sets of restriction fragments may be visualized by PCR without knowledge of nucleotide sequence. The method allows the specific co-amplification of high numbers of restriction fragments. The number of fragments that can be analyzed simultaneously, however, is dependent on the resolution of the detection system. Typically 50-100 restriction fragments are amplified and detected on denaturing polyacrylamide gels. The AFLP technique provides a novel and very powerful DNA fingerprinting technique for DNAs of any origin or complexity.     

Rapid genetic identification and mapping of enzymatically amplified ribosomal DNA from several Cryptococcus species.

Detailed restriction analyses of many samples often require substantial amounts of time and effort for DNA extraction, restriction digests, Southern blotting, and hybridization. We describe a novel approach that uses the polymerase chain reaction (PCR) for rapid simplified restriction typing and mapping of DNA from many different isolates. DNA fragments up to 2 kilobase pairs in length were efficiently amplified from crude DNA samples of several pathogenic Cryptococcus species, including C. neoformans, C. albidus, C. laurentii, and C. uniguttulatus. Digestion and electrophoresis of the PCR products by using frequent-cutting restriction enzymes produced complex restriction phenotypes (fingerprints) that were often unique for each strain or species. We used the PCR to amplify and analyze restriction pattern variation within three major portions of the ribosomal DNA (rDNA) repeats from these fungi. Detailed mapping of many restriction sites within the rDNA locus was determined by fingerprint analysis of progressively larger PCR fragments sharing a common primer site at one end. As judged by PCR fingerprints, the rDNA of 19 C. neoformans isolates showed no variation for four restriction enzymes that we surveyed. Other Cryptococcus spp. showed varying levels of restriction pattern variation within their rDNAs and were shown to be genetically distinct from C. neoformans. The PCR primers used in this study have also been successfully applied for amplification of rDNAs from other pathogenic and nonpathogenic fungi, including Candida spp., and ought to have wide applicability for clinical detection and other studies.     

利用扩增片段长度多态性分析鉴别炭疽和蜡样芽孢杆菌

目的:利用扩增片段长度多态性(AFLP)分析建立鉴别炭疽芽孢杆菌和蜡样芽孢杆菌的分子生物学方法。方法:3株炭疽芽孢杆菌和3株蜡样芽孢杆菌基因组经限制性内切酶EcoRⅠ和MseⅠ酶切后与对应接头连接,通过预扩增和选择性扩增获得特异性DNA片段,将片段进行毛细管电泳,并利用GeneScan和BioNumerics软件对电泳数据进行分析。结果:选择性扩增最佳引物组合为EcoRⅠ-G/MseⅠ-A,其扩增片段在100~500 bp范围内的有效数量为40~50条;比较炭疽芽孢杆菌和蜡样芽孢杆菌的AFLP特征峰值图和DNA指纹图谱,确定了5个有明显差异的片段区。结论:利用AFLP分析可对芽孢杆菌属中相近的炭疽芽孢杆菌和蜡样芽孢杆菌进行鉴别,该方法可作为炭疽芽孢杆菌传统鉴定方法的补充。     

AFLP分子标记技术及其在动物学研究中的应用

扩增片段长度多态性技术(AFLP)基于选择性扩增完全酶切消化后的基因组DNA片段,包括酶切与连接、选择性扩增、检测分析等3个步骤。该技术的运用不需要预知基因组的序列特征,具有较高的多态分辨力,产生的标记是显性标记,可适用于任何来源和各种复杂度的DNA。自AFLP技术问世以来,在酶切、扩增体系、检测和分析方法等方面不断得到改进。本文将以线虫、昆虫、鱼类、鸟类、家畜、鼠、人等为例,介绍近年来AHLP技术在动物或人的遗传图谱构建和QTL(quantitative trait loci)定位、生物多样性、性别决定和繁殖行为研究、疾病及疾病诊断研究等上的应用。     

DNA Fingerprinting and Analysis of Population Structure in the Chestnut Blight Fungus, Cryphonectria Parasitica

We analyzed DNA fingerprints in the chestnut blight fungus, Cryphonectria parasitica, for stability, inheritance, linkage and variability in a natural population. DNA fingerprints resulting from hybridization with a dispersed moderately repetitive DNA sequence of C. parasitica in plasmid pMS5.1 hybridized to 6-17 restriction fragments per individual isolate. In a laboratory cross and from progeny from a single perithecium collected from a field population, the presence/absence of 11 fragments in the laboratory cross and 12 fragments in the field progeny set segregated in 1:1 ratios. Two fragments in each progeny set cosegregated; no other linkage was detected among the segregating fragments. Mutations, identified by missing bands, were detected for only one fragment in which 4 of 43 progeny lacked a band present in both parents; no novel fragments were detected in any progeny. All other fragments appeared to be stably inherited. Hybridization patterns did not change during vegetative growth or sporulation. However, fingerprint patterns of single conidial isolates of strains EP155 and EP67 were found to be heterogenous due to mutations that occurred during culturing in the laboratory since these strains were first isolated in 1976-1977. In a population sample of 39 C. parasitica isolates, we found 33 different fingerprint patterns with pMS5.1. Most isolates differed from all other isolates by the presence or absence of several fragments. Six fingerprint patterns each occurred twice. Isolates with identical fingerprints occurred in cankers on the same chestnut stems three times; isolates within the other three pairs were isolated from cankers more than 5 m apart. The null hypothesis of random mating in this population could not be rejected if the six putative clones were removed from the analysis. Thus, a rough estimate of the clonal fraction of this population is 6 in 39 isolates (15.4%).